Top Page
Xtract One
(TSX:XTRA)
Xtract One (XTRA) vs. iShares MSCI Canada ETF (EWC)
Xtract One Business Overview & Revenue Model
Xtract One Earnings Call Summary
Xtract One Financial Statement Overview
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 13.85M | 16.36M | 4.11M | 3.62M | 1.08M |
| Gross Profit | 7.55M | 10.26M | 2.38M | 3.34M | 1.05M |
| EBITDA | -9.54M | -8.96M | -14.24M | -13.04M | -11.45M |
| Net Income | -11.88M | -11.06M | -16.34M | -39.72M | -16.56M |
Balance Sheet | |||||
| Total Assets | 23.41M | 24.94M | 19.00M | 18.06M | 49.40M |
| Cash, Cash Equivalents and Short-Term Investments | 8.22M | 8.63M | 8.33M | 6.28M | 9.65M |
| Total Debt | 1.13M | 380.93K | 356.84K | 677.28K | 985.92K |
| Total Liabilities | 12.73M | 10.97M | 4.26M | 3.51M | 2.56M |
| Stockholders Equity | 10.69M | 13.97M | 14.74M | 14.55M | 46.84M |
Cash Flow | |||||
| Free Cash Flow | -6.73M | -8.57M | -13.57M | -9.37M | -12.26M |
| Operating Cash Flow | -6.54M | -8.14M | -13.54M | -9.27M | -11.69M |
| Investing Cash Flow | -756.71K | -429.75K | 364.46K | -95.76K | -544.96K |
| Financing Cash Flow | 6.90M | 8.87M | 15.22M | 5.99M | -514.96K |
Xtract One Technical Analysis
Xtract One Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | C$131.39M | -43.63 | -8.89% | 0.71% | -4.89% | -143.94% | |
55 Neutral | C$148.58M | 137.40 | 24.43% | ― | 20.62% | 21.78% | |
52 Neutral | C$159.10M | -12.31 | -108.12% | ― | -12.14% | 4.41% | |
51 Neutral | C$202.72M | -5.83 | -31.23% | ― | 13.16% | -1375.61% | |
46 Neutral | C$139.85M | -46.56 | -14.10% | ― | 48.18% | -401.19% | |
41 Neutral | C$73.62M | -78.16 | -144.12% | ― | -10.57% | -117.50% |
Xtract One Corporate Events
Xtract One Technologies has secured a contract with a major nationwide healthcare provider to implement its SmartGateway solution across clinics in the Midwest, starting with five locations in Minnesota. This deployment addresses heightened safety concerns in healthcare environments, offering a modern, non-invasive security technology that balances protection with a welcoming experience. The SmartGateway system, backed by the U.S. Department of Homeland Security’s SAFETY Act, uses advanced AI technology for discreet and efficient weapons detection, enhancing security without compromising the patient and staff experience.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies reported its fiscal first quarter results for 2026, highlighting a revenue increase to $4.6 million from $3.6 million in the previous year, despite a decrease in gross margin from 64% to 58%. The company has a total backlog exceeding $53 million, indicating strong demand for its Xtract One Gateway product, which has led to new bookings worth $5.1 million from seven customers. The company successfully raised $11.5 million through a public offering, positioning itself for significant growth and improved margins in the latter half of fiscal 2026.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies has been selected by Nova Scotia Health to deploy its SmartGateway systems across healthcare facilities in the province, aiming to enhance security and protect healthcare workers, patients, and visitors. This initiative addresses the increasing violence against healthcare workers and expands Xtract One’s presence in the Canadian healthcare sector, following successful deployments in other regions. The SmartGateway system, which uses AI-powered sensors for discreet and efficient weapons detection, was proven effective during a trial in Truro, Nova Scotia, and is expected to significantly bolster security measures and ensure safer environments in healthcare settings.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies announced the release of its fiscal 2026 first quarter results, scheduled for December 3, 2025, with a subsequent webcast and conference call on December 4, 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and future outlook, reinforcing its position in the threat detection and security industry.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies announced the results of its annual general and special meeting of shareholders, where all company nominees were elected as directors. The meeting also approved key resolutions, including setting the number of directors to five, appointing Davidson & Company LLP as auditors, and re-approving the company’s Omnibus Equity Incentive Plan. These decisions are expected to strengthen the company’s governance and operational framework, reinforcing its position in the security technology industry.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies has successfully closed an $11.5 million bought deal public offering, which included the full exercise of the over-allotment option. The proceeds from this offering are intended for working capital and general corporate purposes, potentially strengthening the company’s operational capabilities and market position in the threat detection industry.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies has announced a $10 million bought deal offering, partnering with a syndicate of underwriters led by Stifel Canada. This offering, consisting of 13,334,000 units at $0.75 per unit, aims to raise funds for working capital and general corporate purposes. The offering is expected to close on November 10, 2025, pending necessary approvals. This move is likely to strengthen Xtract One’s market position and operational capabilities, potentially benefiting stakeholders by enhancing the company’s financial stability and capacity to innovate in the security solutions industry.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies reported its fiscal 2025 results, highlighting a significant backlog of nearly $50 million and expectations for revenue acceleration in fiscal 2026. Despite a revenue shortfall due to timing and manufacturing challenges, the company experienced strong demand for its Xtract One Gateway, with total bookings of $13.1 million from nine new customers across various sectors. The company anticipates a bright future with the successful commercial deployment of its Gateway, aiming for fiscal 2026 to be its best year yet.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies announced it will release its fiscal 2025 annual and fourth-quarter results on October 23, 2025, with a webcast and conference call scheduled for the following day. The announcement highlights the company’s focus on leveraging AI for security solutions, positioning it as a market leader in providing seamless and secure access experiences, which may impact its operations and stakeholder engagement.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.